1. Home
  2. NSSC vs NNNN Comparison

NSSC vs NNNN Comparison

Compare NSSC & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$38.24

Market Cap

1.4B

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$23.92

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
NNNN
Founded
1969
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
NSSC
NNNN
Price
$38.24
$23.92
Analyst Decision
Strong Buy
Analyst Count
6
0
Target Price
$48.17
N/A
AVG Volume (30 Days)
849.8K
26.3K
Earning Date
05-04-2026
04-28-2026
Dividend Yield
1.54%
N/A
EPS Growth
N/A
N/A
EPS
0.72
N/A
Revenue
$181,621,000.00
N/A
Revenue This Year
$13.63
N/A
Revenue Next Year
$10.05
N/A
P/E Ratio
$54.00
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$19.63
$5.91
52 Week High
$47.61
$55.65

Technical Indicators

Market Signals
Indicator
NSSC
NNNN
Relative Strength Index (RSI) 34.06 52.80
Support Level $37.41 $19.53
Resistance Level $44.43 $30.70
Average True Range (ATR) 1.50 1.97
MACD -0.49 0.41
Stochastic Oscillator 3.46 84.48

Price Performance

Historical Comparison
NSSC
NNNN

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: